Clinical Quality Insights for Complex Trials.

ARTICLES

Articles

Practical perspectives from the VedX Clinical team.

• GxP Audits

  How GxP Audits Find Gaps Before They Become Findings

  A well-run GxP audit surfaces the process, documentation and oversight gaps that inspectors would otherwise find first — before they turn into formal findings.

• Inspection Readiness

  Preparing for Regulatory Inspection: Beyond the Document Checklist

  Inspection readiness is more than a document review. It means challenging your team with the questions inspectors actually ask, and knowing where the real gaps are.

• Critical Vendor & System Audits

  Critical Vendor Audits: Protecting the Endpoints That Matter

  Central imaging, adjudication, eCOA and other endpoint vendors can influence trial outcomes directly. Independent oversight of these partners protects data integrity.

• CAPA & Risk-Based Quality Management

  CAPA and RBQM: Turning Root-Cause Analysis into Lasting Improvement

  A CAPA that doesn't address root cause is a CAPA that recurs. Pairing root-cause analysis with risk-based quality management builds fixes that actually hold.

• Quality System & QMS Improvement

  Building a Scalable Quality System for Growing Biotechs and CROs

  A quality system built for a five-person team won't hold up at fifty. Practical, scalable frameworks let emerging biotechs and CROs grow without losing control.

• Technology & Solutions

  Clinical Technology Audits: eTMF, CTMS, eCOA/ePRO and IRT/RTSM

  Clinical systems carry as much compliance risk as clinical processes. Independent technology audits assess validation, data integrity and operational controls.